Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 378 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Comparative Effectiveness and Safety of Ustekinumab Versus Anti-Tumour Necrosis Factor Agents As First- or Second-Line Biologics in Crohns Disease: a Real-World Multicentric Observational Study
S. Ferreira,R. Serafim Parra,L. Yukie Sassaki, M. Kurtz de Mello, J. M. Luz Parente, M. Bafutto, F. G. Cancela Penna, L. Penna Pinho, R. de Sa Brito Froes, Gasparetti, L. Andrade Chebli, A. J. Tiburcio Alves Jr, F. J. Firmino Nobrega, A. Botelho Quaresma, G. Mattioli Nicollelli,R. Galhardi Gasparini, R. de Medeiros Dutra, D. Oliveira Magro, M. Gardere Camargo, L. Palha Dias Parente,O. Feres, L. E. de Almeida Troncon,P. G. Kotze, J. M. Fonseca Chebli
JOURNAL OF CROHNS & COLITIS (2025): i1637-i1638
Cited0Views0Bibtex
0
0
Effectiveness, Safety and Predictors of Response to Vedolizumab As First- or Second-Line Biological Therapy in Patients with Ulcerative Colitis: A Real-World Observational Multicenter Study
S. Ferreira,R. Serafim Parra,L. Yukie Sassaki, J. M. Luz Parente, M. Kurtz de Mello, L. Andrade Chebli, R. L. Luporini, A. J. Tiburcio Alves Junior, F. J. Firmino Nobrega, B. C. da Silva,E. F. Miranda, A. Botelho Quaresma, G. Mattioli Nicollelli,R. Galhardi Gasparini, R. de Medeiros Dutra, K. da Conceicao da Silva, D. Oliveira Magro, M. R. Imbrizi, C. Kibune Nagasako,O. Feres, L. E. de Almeida Troncon,P. G. Kotze, J. M. Fonseca Chebli
JOURNAL OF CROHNS & COLITIS (2025): i1335-i1336
Cited0Views0Bibtex
0
0
P1176 Low Serum Albumin Levels Are Associated with Higher Colectomy Rates in Patients with Moderate-to-severe Ulcerative Colitis on Tofacitinib
R. Parra PhD,R. D. S. B. Froes,D. O. Magro,S. D. C. Ferreira, M. K. D. Mello, M. F. C. D. Azevedo,A. O. M. C. Damiao, A. D. S. Carlos,L. L. Barros, M. L. Q. D. Miranda,G. P. Zabot, A. Vieira, M. P. M. Sales,L. A. Chebli,O. S. Cassol,M. Lubini, A. J. T. Alves Jr, M. B. Machado, C. Flores,F. Teixeira,C. S. R. Coy,C. Zaltman,L. Y. Sassaki,O. Feres,J. M. F. Chebli
JOURNAL OF CROHNS & COLITIS (2025): i2145-i2145
Cited0Views0Bibtex
0
0
Sa1840 FACTORS ASSOCIATED WITH DELAYED DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE AND RISK OF COMPLICATIONS: ANALYSIS OF THE BRAZILIAN NATIONAL REGISTRY
Adriana R. Andrade, Mikaell A. Faria,Renata Froes,Ligia Y. Sassaki, Jose Miguel L. Parente, Roberto L. Kaiser, Carlos Henrique M. dos Santos,Rogerio S. Parra,Genoile O. Santana,Mauro Bafutto, Rafael L. Luporine, Abel B. Quaresma,Rogerio S. Hossne,Neogelia P. Almeida,Gilmara P. Zabot, Jaciane M. Fontes, Valeria C. Salgado, Silvia F. Araujo, Heitor S. De Souza, Fabio L. Maximiano, Catiane R. Nascimento, Giedre S. Herrerias, Camila V. Chiquetti, Flora M. Fortes, Maria Clara P. Lopes, Bernardo J. de Carvalho, Pedro G. Pertence, Gabriela L. Bezerra,Omar Feres, Joao V. Feldmann,Cristina Flores
Journal of Crohn s and Colitisno. Supplement_1 (2024): i1992-i1993
Cited0Views0Bibtex
0
0
P558 Clinical Effectiveness and Safety of Vedolizumab Vs. Infliximab in Biologic-Naïve Ulcerative Colitis Patients: A Brazilian Real-World Multicentric Observational Study
S. Ferreira,J. M. F. Chebli,R. Parra,L. Yukie Sassaki, M. K. de Mello, R. L. Luporini,L. A. Chebli, F. J. Firmino Nobrega,B. C. da Silva, R. D. M. Dutra, J. R. de Oliveira Vasconcelos, M. P. Moraes Sales,O. Feres,J. M. L. Parente, L. E. D. A. Troncon
Journal of Crohn's and Colitisno. Supplement_1 (2024)
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 385

#Citation: 2164

H-Index: 24

G-Index: 33

Sociability: 7

Diversity: 3

Activity: 24

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn